We here evaluated the potential anti-colorectal cancer activity by erastin, a

We here evaluated the potential anti-colorectal cancer activity by erastin, a voltage-dependent anion channel (VDAC)-binding compound. colorectal cancer cells. On the other hand, over-expression of VDAC-1 augmented erastin-induced ROS production, mPTP opening, and colorectal cancer cell apoptosis. studies showed that PF-562271 intraperitoneal injection of erastin at well-tolerated doses dramatically inhibited HT-29 xenograft growth in severe… Continue reading We here evaluated the potential anti-colorectal cancer activity by erastin, a